1478629

Ondansetron Related Compound D

United States Pharmacopeia (USP) Reference Standard

• Sinónimos: 9-Methyl-3-methylene-1,2,3,9-tetrahydro-4H-carbazol-4-one, 1,2,3,9-Tetrahydro-9-methyl-3-methylene-4H-carbazol-4-one
• Fórmula empírica (notación de Hill): C₁₄H₁₃NO
• Número de CAS: 99614-64-9
• Peso molecular: 211.26
• Beilstein: 7920329
• Número MDL: MFCD08063682
• Código UNSPSC: 41116107
• ID de la sustancia en PubChem: 329750615
• NACRES: NA.24

Propiedades

• grado: pharmaceutical primary standard
• familia API: ondansetron
• fabricante / nombre comercial: USP
• aplicaciones: pharmaceutical (small molecule)
• Formato: neat
• cadena SMILES: Cn1c2CCC(=C)C(=O)c2c3ccccc13
• InChI: 1S/C14H13NO/c1-9-7-8-12-13(14(9)16)10-5-3-4-6-11(10)15(12)2/h3-6H,1,7-8H2,2H3
• Clave InChI: AGQJDIDJKSFVTC-UHFFFAOYSA-N

Descripción

Descripción general

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Aplicación

Ondansetron Related Compound D USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia.
Also, for use with USP monographs such as:

• Ondansetron Oral Solution
• Ondansetron Injection
• Ondansetron
• Ondansetron Hydrochloride
• Ondansetron Orally Disintegrating Tablets

Nota de análisis

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Otras notas

Sales restrictions may apply.